Reappraise role of No. 10 lymphadenectomy for proximal gastric cancer in the era of minimal invasive surgery during total gastrectomy: a pooled analysis of 4 prospective trial.
Qing ZhongQi-Yue ChenYan-Chang XuGang ZhaoLi-Sheng CaiGuo-Xin LiZe-Kuan XuSu YanZu-Guang WuFang-Qin XueYi-Hong SunDong-Po XuWen-Bin ZhangJin WanPei-Wu YuJian-Kun HuXiang-Qian SuJia-Fu JiZi-Yu LiJun YouYong LiLin FanChao-Hui ZhengJian-Wei XiePing LiChang-Ming HuangPublished in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2020)
LSPSHL for LAPGC is safe and feasible when performed by experienced surgeons. LSPSHL could be recommended for the high-priority group patients even without invasion of the Gre.
Keyphrases
- end stage renal disease
- minimally invasive
- newly diagnosed
- ejection fraction
- chronic kidney disease
- clinical trial
- early stage
- phase iii
- lymph node
- prognostic factors
- peritoneal dialysis
- study protocol
- squamous cell carcinoma
- lymph node metastasis
- randomized controlled trial
- coronary artery disease
- patient reported outcomes
- acute coronary syndrome
- cell migration
- robot assisted
- patient reported
- percutaneous coronary intervention